| # | Drug | Count |
|---|---|---|
| 0 | ONABOTULINUMTOXINA | 43 |
| 1 | ADALIMUMAB | 40 |
| 2 | GLATIRAMER ACETATE | 32 |
| 3 | DUPILUMAB | 16 |
| 4 | ERGOCALCIFEROL | 16 |
| 5 | BOTULINUM TOXIN TYPE A | 12 |
| 6 | INTERFERON BETA-1A | 12 |
| 7 | DEOXYCHOLIC ACID | 11 |
| 8 | GABAPENTIN | 10 |
| 9 | SERTRALINE | 10 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ADALIMUMAB-ADBM | 2 | 0.0075 |
| 1 | DEOXYCHOLIC ACID | 11 | 0.0047 |
| 2 | FLURANDRENOLIDE | 1 | 0.0030 |
| 3 | VIMSELTINIB | 1 | 0.0018 |
| 4 | GONADOTROPHIN, CHORIONIC | 1 | 0.0016 |
| 5 | BEMPEDOIC ACID AND EZETIMIBE | 1 | 0.0014 |
| 6 | MONOMETHYL FUMARATE | 1 | 0.0011 |
| 7 | BOTULINUM TOXIN TYPE A | 12 | 0.0009 |
| 8 | ESTRADIOL, FOLLICULINUM, OOPHORINUM (SUIS) | 2 | 0.0009 |
| 9 | HYALURONIC ACID | 1 | 0.0009 |
| # | Drug class | Count |
|---|---|---|
| 0 | Acetylcholine Release Inhibitor [EPC] | 59 |
| 1 | Neuromuscular Blocker [EPC] | 59 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 19 |
| 3 | Corticosteroid [EPC] | 16 |
| 4 | Interleukin-4 Receptor alpha Antagonist [EPC] | 16 |
| 5 | Insulin Analog [EPC] | 12 |
| 6 | Interferon beta [EPC] | 12 |
| 7 | Estrogen [EPC] | 11 |
| 8 | Vitamin C [EPC] | 11 |
| 9 | GLP-1 Receptor Agonist [EPC] | 9 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Acetylcholine Release Inhibitor [EPC] | 59 | 0.0006 |
| 1 | Endoglycosidase [EPC] | 1 | 0.0005 |
| 2 | Neurokinin 3 Receptor Antagonist [EPC] | 1 | 0.0004 |
| 3 | Monoamine Oxidase Inhibitor [EPC] | 1 | 0.0003 |
| 4 | Adenosine Triphosphate-Citrate Lyase Inhibitor [EPC] | 1 | 0.0003 |
| 5 | Serotonin and Norepinephrine Reuptake Inhibitor [EPC] | 1 | 0.0003 |
| 6 | Dopamine and Norepinephrine Reuptake Inhibitor [EPC] | 1 | 0.0003 |
| 7 | Antihypoglycemic Agent [EPC] | 1 | 0.0002 |
| 8 | Parathyroid Hormone-Related Peptide Analog [EPC] | 5 | 0.0002 |
| 9 | PCSK9 Inhibitor [EPC] | 4 | 0.0002 |